 The introduction of HPV vaccination in China aims to prevent infection but may face challenges such as high cost of imported vaccines, shortage in supply, negative events attributed to vaccination, cultural and literacy barriers, and sensitivity to receiving a vaccine for a sexually transmitted disease. Ensuring effective delivery will require significant resources, including locally manufactured vaccines and evidence supporting a two-dose regime for younger adolescents to enhance compliance and uptake, especially in remote regions.